| Marktkapitalisierung | 241 Mio. 210 Mio. 199 Mio. 181 Mio. 338 Mio. 23.11 Mrd. 339 Mio. 2.37 Mrd. 916 Mio. 11.75 Mrd. 907 Mio. 886 Mio. 37.61 Mrd. | KGV 2026 * |
-17.2x | KGV 2027 * | -15.3x |
|---|---|---|---|---|---|
| Enterprise Value (EV) | 241 Mio. 210 Mio. 199 Mio. 181 Mio. 338 Mio. 23.11 Mrd. 339 Mio. 2.37 Mrd. 916 Mio. 11.75 Mrd. 907 Mio. 886 Mio. 37.61 Mrd. | EV / Umsatz 2026 * |
-
| EV / Umsatz 2027 * | - |
| Streubesitz |
-
| Rendite 2026 * |
-
| Rendite 2027 * | - |
Aktuelles Transkript: Foamix Pharmaceuticals Ltd.
| % | % 5 Tage | Perf. 1 Jahr | Perf. 3 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -16.94% | - | - | 19.05 Mio. | |
| +1.76% | +3.62% | +49.92% | +101.12% | 69.69 Mrd. | |
| +2.29% | +1.43% | +38.39% | +77.03% | 61.24 Mrd. | |
| +1.14% | -2.59% | -14.37% | +365.92% | 26.77 Mrd. | |
| +0.32% | +2.58% | +29.26% | +14.12% | 26.12 Mrd. | |
| +2.95% | +2.34% | +0.52% | -12.74% | 24.07 Mrd. | |
| +1.49% | +5.15% | +26.46% | -15.89% | 20.39 Mrd. | |
| -0.83% | -11.15% | +169.70% | +295.44% | 15.72 Mrd. | |
| +3.01% | +1.85% | +44.63% | +168.18% | 14.07 Mrd. | |
| +0.17% | -4.07% | -9.71% | +484.05% | 14.03 Mrd. | |
| Durchschnitt | +1.23% | -1.18% | +37.20% | +164.14% | 30.23 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +1.60% | +0.20% | +36.46% | +129.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Umsatz | - | - |
| Nettoergebnis | -38.54 Mio. -33.57 Mio. -31.77 Mio. -28.87 Mio. -53.93 Mio. -3.69 Mrd. -54.2 Mio. -378 Mio. -146 Mio. -1.88 Mrd. -145 Mio. -142 Mio. -6.01 Mrd. | -66.89 Mio. -58.27 Mio. -55.14 Mio. -50.1 Mio. -93.6 Mio. -6.41 Mrd. -94.06 Mio. -657 Mio. -254 Mio. -3.26 Mrd. -251 Mio. -246 Mio. -10.42 Mrd. |
| Nettoverschuldung | - | - |
Beschäftigte
-
Sektor
Biotechnologie
